NDC 54868-4535-2 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4535
- Requested NDC
- 54868-4535-2
- Package NDCs from labels
- 54868-4535-1, 54868-4535-2
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4535-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4535-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4535 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4535-0 | EA - Each | 54868-4535 | b4aef346-caf3-4da3-8d9d-1925e154fab5 | 1 | 2012-07-24 |
| 54868-4535-1 | EA - Each | 54868-4535 | e84f8d98-5131-4014-927f-495343aa1e72 | 1 | 2012-07-24 |
| 54868-4535-2 | EA - Each | 54868-4535 | 2dc70794-405b-4bee-8a56-d732a9fcb6e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 88ad2e92-2228-49b2-bcee-1770fd30cb14 | 2025-12-04 | Warnings | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2adb05ef-b3fa-4ac2-b219-99442746392b | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | d5b005e8-a88d-450b-bbc3-393d885260f5 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | c29a417b-95b0-4c9b-85e6-ec884049edb1 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| BM Sodium bicarbonate (Nat Bicarb) | SODIUM BICARBONATE | BM Private Limited | 38044eae-7237-6add-e063-6294a90a827b | 2025-12-02 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3453af75-8c2e-421f-9a08-24751936df41 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1af49c9f-93da-4838-899b-9445083a154b | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | bd84ca00-6352-4cb3-bce2-05f4a5005a94 | 2025-11-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Civica | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 2025-11-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Glenmark Pharmaceuticals Inc., USA | f38d0dfc-9bcc-4224-a202-885c9ad0beae | 2025-11-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Itch Eraser Sensitive | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 2250525a-45c2-42ea-e063-6394a90ac001 | 2025-11-18 | Warnings | 8MDF5V39QO |
| After Bite Kids | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 226c1420-d771-204f-e063-6294a90af9f6 | 2025-11-18 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fea284d8-0514-498b-a37c-405730b5f6a2 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | 8MDF5V39QO |
| After Bite X Tech | SODIUM BICARBONATE | Adventure Ready Brands | e9e49ab4-3e1f-9fd4-e053-2a95a90a775a | 2025-11-17 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2025-11-10 | Warnings | 8MDF5V39QO |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 27dbf0bf-c273-2108-e063-6394a90a0a09 | 2025-11-10 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.